Preparation method and application of drug-loading and permeation-promoting integrated transdermal drug delivery system matrix
A delivery system and drug technology, applied in the field of transdermal drug delivery system, can solve problems such as toxic side effects, limit the development of transdermal drug delivery system, and achieve the effect of avoiding irritation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0036] The present invention proposes a method for preparing a drug-loaded permeation-promoting integrated transdermal drug delivery system matrix. The preparation method of the drug-loaded permeation-promoting integrated transdermal drug delivery system matrix includes the following steps:
[0037] S10, after mixing the hydrogen bond donor and the hydrogen bond acceptor, heating to form a deep eutectic solvent;
[0038] In this embodiment, the hydrogen bond acceptor includes any one of L-diethyl tartrate, L-tartaric acid, citric acid, malonic acid, cinnamic acid, triglyceride, and cinnamate. Donors include choline chloride. In the present invention, the hydrogen bond donors in the ratio of the deep eutectic solvent include but are not limited to choline chloride, betaine and other hydrogen bond donors and hydrochloric acid thereof Salt. In the present embodiment, the hydrogen bond donor is preferably choline chloride, the hydrogen bond acceptor is preferably L-diethyl tartra...
Embodiment 1
[0051] (1) Heating choline chloride and diethyl L-tartrate at a molar ratio of 1:2 at 70°C for 30 minutes to form a transparent and uniform deep eutectic solvent, named CL12;
[0052] (2) Diclofenac diethylamine (60 mg / mL) was added to CL12, heated and dissolved to obtain the drug-loaded permeation-promoting integrated transdermal drug delivery system matrix, which was named CL12D.
[0053] (3) Apply CL12D on the non-woven fabric.
Embodiment 2
[0055] (1) Heating choline chloride and diethyl L-tartrate at a molar ratio of 1:4 at 70°C for 30 minutes to form a transparent and uniform deep eutectic solvent, named CL14;
[0056] (2) Diclofenac diethylamine (60 mg / mL) was added to CL14, heated and dissolved to obtain the drug-loaded permeation-promoting integrated transdermal drug delivery system matrix, which was named CL14D.
[0057] (3) Apply CL14D on the non-woven fabric.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com